🇺🇸 FDA
Patent

US 9657066

Pseudomonas exotoxin A with less immunogenic B cell epitopes

granted A61KA61K38/00A61K38/164

Quick answer

US patent 9657066 (Pseudomonas exotoxin A with less immunogenic B cell epitopes) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue May 23 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K38/00, A61K38/164, A61K47/6829, A61P